Analysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cencora (COR – Research Report), Cormedix (CRMD – Research Report) and NeueHealth Inc (NEUE – Research Report).

Cencora (COR)

In a report released yesterday, Allen Lutz from Bank of America Securities maintained a Buy rating on Cencora, with a price target of $256.00. The company’s shares closed last Tuesday at $237.44, close to its 52-week high of $240.44.

According to TipRanks.com, Lutz is a 1-star analyst with an average return of -2.8% and a 49.4% success rate. Lutz covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, Walgreens Boots Alliance, and Patterson Companies.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cencora with a $249.75 average price target, which is a 5.1% upside from current levels. In a report issued on February 26, Leerink Partners also initiated coverage with a Buy rating on the stock with a $261.00 price target.

See the top stocks recommended by analysts >>

Cormedix (CRMD)

In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Cormedix, with a price target of $9.00. The company’s shares closed last Tuesday at $3.42.

According to TipRanks.com, Renza is a 5-star analyst with an average return of 15.5% and a 46.0% success rate. Renza covers the Healthcare sector, focusing on stocks such as Verrica Pharmaceuticals, Fusion Pharmaceuticals, and Pacira Pharmaceuticals.

Currently, the analyst consensus on Cormedix is a Strong Buy with an average price target of $13.00, which is a 279.0% upside from current levels. In a report released yesterday, Needham also maintained a Buy rating on the stock with a $10.00 price target.

NeueHealth Inc (NEUE)

In a report released today, Ben Hendrix from RBC Capital maintained a Hold rating on NeueHealth Inc, with a price target of $8.00. The company’s shares closed last Tuesday at $7.47, close to its 52-week low of $4.94.

According to TipRanks.com, Hendrix is a 4-star analyst with an average return of 3.8% and a 57.6% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Brookdale Senior Living, and Acadia Healthcare.

Currently, the analyst consensus on NeueHealth Inc is a Hold with an average price target of $8.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on COR:

• Cencora Announces CEO Change, Reaffirms 2024 Financial Outlook
• Cencora initiated with an Outperform at Leerink
• FTC probing drug distributors over low supplies of chemotherapies, WSJ reports
• Cencora Significant Share Sale Alters Ownership Stake
• Cencora Buys Back Shares to Boost Shareholder Value